Aridis Pharmaceuticals Inc
NASDAQ:ARDS
Income Statement
Earnings Waterfall
Aridis Pharmaceuticals Inc
Revenue
|
22.4m
USD
|
Operating Expenses
|
-23.2m
USD
|
Operating Income
|
-883k
USD
|
Other Expenses
|
-259k
USD
|
Net Income
|
-1.1m
USD
|
Income Statement
Aridis Pharmaceuticals Inc
Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | ||
---|---|---|---|---|---|---|---|---|---|
Revenue | |||||||||
Revenue |
2
N/A
|
3
+77%
|
3
+10%
|
3
-4%
|
3
+8%
|
3
-3%
|
22
+648%
|
22
+0%
|
|
Operating Income | |||||||||
Operating Expenses |
(44)
|
(45)
|
(48)
|
(34)
|
(33)
|
(32)
|
(30)
|
(23)
|
|
Selling, General & Administrative |
(7)
|
(8)
|
(8)
|
(8)
|
(7)
|
(7)
|
(6)
|
(6)
|
|
Research & Development |
(37)
|
(38)
|
(40)
|
(26)
|
(26)
|
(25)
|
(23)
|
(17)
|
|
Operating Income |
(43)
N/A
|
(43)
+0%
|
(45)
-5%
|
(31)
+30%
|
(30)
+4%
|
(29)
+4%
|
(7)
+74%
|
(1)
+88%
|
|
Pre-Tax Income | |||||||||
Interest Income Expense |
(0)
|
(0)
|
(0)
|
(1)
|
(0)
|
0
|
0
|
0
|
|
Non-Reccuring Items |
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Total Other Income |
0
|
(0)
|
(0)
|
(1)
|
(0)
|
(1)
|
(2)
|
(0)
|
|
Pre-Tax Income |
(42)
N/A
|
(43)
-2%
|
(46)
-6%
|
(33)
+28%
|
(30)
+7%
|
(29)
+3%
|
(9)
+68%
|
(1)
+88%
|
|
Net Income | |||||||||
Income from Continuing Operations |
(42)
|
(43)
|
(46)
|
(33)
|
(30)
|
(29)
|
(9)
|
(1)
|
|
Net Income (Common) |
(46)
N/A
|
(46)
+0%
|
(49)
-5%
|
(33)
+33%
|
(30)
+7%
|
(29)
+3%
|
(9)
+68%
|
(1)
+88%
|
|
EPS (Diluted) |
-3.77
N/A
|
-2.61
+31%
|
-2.75
-5%
|
-1.85
+33%
|
-1.62
+12%
|
-0.96
+41%
|
-0.25
+74%
|
-0.03
+88%
|